Research graph
References from Oral delivery of recombinant Lactococcus lactis expressing an IL-23 inhibitor as a potential therapeutic strategy for experimental colitis. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/mi.2015.65
10.1038/mi.2015.65 · External reference
10.4049/jimmunol.177.5.2760
10.4049/jimmunol.177.5.2760 · External reference
Novel applications of recombinant lactic acid bacteria in therapy and in metabolic engineering
10.2174/187220809788700175 · 2009 · External reference
Lactic acid bacteria as oral delivery systems for biomolecules
10.31083/ph.2012.1705 · 2012 · External reference
10.1016/j.intimp.2016.12.027
10.1016/j.intimp.2016.12.027 · External reference
10.1016/j.cgh.2006.03.028
10.1016/j.cgh.2006.03.028 · External reference
10.1038/mi.2011.54
10.1038/mi.2011.54 · External reference
A genome-wide association study identifies il23r as an inflammatory bowel disease gene
10.1126/science.1135245 · 2006 · External reference
10.1053/j.gastro.2007.03.104
10.1053/j.gastro.2007.03.104 · External reference
A guide to histomorphological evaluation of intestinal inflammation in mouse models
2014 · External reference
10.1016/s0140-6736(17)30570-6
10.1016/s0140-6736(17)30570-6 · External reference
10.1016/j.immuni.2019.03.017
10.1016/j.immuni.2019.03.017 · External reference
10.1016/j.immuni.2016.02.019
10.1016/j.immuni.2016.02.019 · External reference
10.1586/egh.11.107
10.1586/egh.11.107 · External reference
10.1016/j.immuni.2015.07.008
10.1016/j.immuni.2015.07.008 · External reference
Small protein blockers of human IL-6 receptor alpha inhibit proliferation and migration of cancer cells
10.1186/s12964-024-01630-w · 2024 · External reference
10.1093/ibd/izy142
10.1093/ibd/izy142 · External reference
10.1016/s0140-6736(02)08512-4
10.1016/s0140-6736(02)08512-4 · External reference
10.1038/ni.3153
10.1038/ni.3153 · External reference
10.1016/j.cell.2009.09.033
10.1016/j.cell.2009.09.033 · External reference
Rapid removal of dextran sulfate sodium from tissue RNA preparations for measurement of inflammation biomarkers
10.1016/j.ab.2019.05.011 · 2019 · External reference
10.1016/s1074-7613(00)80038-2
10.1016/s1074-7613(00)80038-2 · External reference
10.1080/08916934.2016.1272598
10.1080/08916934.2016.1272598 · External reference
10.1002/prot.24472
10.1002/prot.24472 · External reference
Human IL-22 receptor-targeted small protein antagonist suppress murine DSS-induced colitis
10.1186/s12964-024-01846-w · 2024 · External reference
IL-23 plays a key role in helicobacter hepaticus-induced T cell-dependent colitis
10.1084/jem.20061082 · 2006 · External reference
10.1136/gutjnl-2014-309014
10.1136/gutjnl-2014-309014 · External reference
10.1006/meth.2001.1262
10.1006/meth.2001.1262 · External reference
Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells
10.1038/mi.2014.78 · 2015 · External reference
IL-23 monoclonal antibodies for IBD: so many, so different?
10.1093/ecco-jcc/jjac038 · 2022 · External reference
Lactic acid bacteria as microbial cell factories for the in vivo delivery of therapeutic proteins as secretable TAT fusion products
10.1186/s13036-025-00538-4 · 2025 · External reference
10.1016/0016-5085(89)90904-9
10.1016/0016-5085(89)90904-9 · External reference
Oral IL-23-blocking peptide racks up phase III wins in inflammatory disease
10.1038/d41573-025-00063-5 · 2025 · External reference
10.1016/0016-5085(90)90290-h
10.1016/0016-5085(90)90290-h · External reference
10.1016/s1074-7613(00)00070-4
10.1016/s1074-7613(00)00070-4 · External reference
Safety aspects of genetically modified lactic acid bacteria
10.3390/microorganisms8020297 · 2020 · External reference
10.1016/j.ejps.2023.106568
10.1016/j.ejps.2023.106568 · External reference
Engineered lactococcus lactis secreting IL-23 receptor-targeted REX protein blockers for modulation of IL-23/Th17-Mediated inflammation
10.3390/microorganisms7050152 · 2019 · External reference
Phenotypically distinct subsets of CD4(+) T-cells induce or protect from chronic intestinal inflammation in C-B-17 SCID mice
10.1093/intimm/5.11.1461 · 1993 · External reference
Efficacy and safety of MEDI2070, an antibody against interleukin 23, in patients with moderate to severe Crohn's disease: a phase 2a study
10.1053/j.gastro.2017.03.049 · 2017 · External reference
The alarmin IL-33 promotes regulatory T-cell function in the intestine
10.1038/nature13577 · 2014 · External reference
10.1136/gutjnl-2011-301785
10.1136/gutjnl-2011-301785 · External reference
Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention
10.1093/ecco-jcc/jjac034 · 2022 · External reference
10.1016/j.immuni.2010.03.017
10.1016/j.immuni.2010.03.017 · External reference
10.1073/pnas.231473998
10.1073/pnas.231473998 · External reference
10.1152/ajpregu.2001.281.4.r1264
10.1152/ajpregu.2001.281.4.r1264 · External reference
p19-Targeting ILP protein blockers of IL-23/Th-17 pro-inflammatory axis displayed on engineered bacteria of food origin
10.3390/ijms19071933 · 2018 · External reference
10.1016/j.bios.2023.115155
10.1016/j.bios.2023.115155 · External reference
10.1038/nri.2017.50
10.1038/nri.2017.50 · External reference
10.1016/j.immuni.2006.05.017
10.1016/j.immuni.2006.05.017 · External reference
The genetics of Crohn's disease
10.1146/annurev-genom-082908-150013 · 2009 · External reference
10.1038/s41575-023-00768-1
10.1038/s41575-023-00768-1 · External reference
10.1007/s00253-016-7557-x
10.1007/s00253-016-7557-x · External reference
10.1186/s13059-016-0901-8
10.1186/s13059-016-0901-8 · External reference
10.1038/nature06005
10.1038/nature06005 · External reference
10.1172/jci21404
10.1172/jci21404 · External reference
10.1080/21655979.2015.1040956
10.1080/21655979.2015.1040956 · External reference
